Stocktoria
STAAR SURGICAL CO STAA
STAAR SURGICAL CO financials (annual)
Bars are annual figures from 2016 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2024 | FY2023 | FY2022 | FY2021 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $239.4M | $313.9M | $322.4M | $239.4M | $230.5M | $163.5M | $150.2M | $124.0M | $90.6M | $82.4M |
| Gross profit | $182.4M | $239.6M | $252.7M | $223.4M | $178.6M | $118.4M | $112.0M | $91.5M | $64.3M | $58.4M |
| R&D expense | $40.1M | $45.3M | $40.5M | $36.0M | $33.9M | $31.9M | $25.3M | $22.0M | $20.0M | $20.7M |
| SG&A expense | $274.1M | $252.2M | $224.6M | $179.6M | $145.3M | $111.6M | $100.1M | $84.9M | $67.9M | $71.0M |
| Operating income | -$91.7M | -$12.6M | $28.1M | $43.8M | $33.3M | $6.8M | $11.9M | $6.6M | -$3.6M | -$12.7M |
| Interest expense | — | — | — | — | — | — | — | — | $112,000 | $112,000 |
| Income tax | -$1.8M | $11.2M | $12.3M | $5.9M | $3.8M | $2.4M | -$1.0M | $1.7M | -$157,000 | -$315,000 |
| Net income | -$80.4M | -$20.2M | $21.3M | $39.7M | $27.5M | $5.9M | $14.0M | $5.0M | -$2.1M | -$12.1M |
| EPS (diluted) | $-1.62 | $-0.41 | $0.43 | $0.80 | $0.56 | $0.12 | $0.30 | $0.11 | $-0.05 | $-0.30 |
| Operating cash flow | -$34.2M | $15.7M | $14.6M | $35.7M | $44.0M | $21.0M | $25.8M | $12.8M | $2.9M | $1.0M |
| Free cash flow | -$40.0M | -$7.7M | -$3.6M | $17.6M | $30.3M | $12.5M | $15.7M | $10.5M | $1.8M | -$2.2M |
| Cash & equivalents | $153.2M | $144.2M | $183.0M | $86.5M | $199.7M | $152.5M | $120.0M | $103.9M | $18.5M | $14.0M |
| Total assets | $451.7M | $509.5M | $488.7M | $418.8M | $345.8M | $257.4M | $207.5M | $167.3M | $67.9M | $65.5M |
| Total liabilities | $107.5M | $112.2M | $102.7M | $82.7M | $87.2M | $60.2M | $47.6M | $34.9M | $25.0M | $27.6M |
| Shareholders' equity | $344.2M | $397.3M | $386.0M | $336.1M | $261.6M | $197.2M | $159.9M | $132.4M | $42.9M | $37.9M |
Growth · year-over-year · Revenue CAGR 12.6%
| Metric | FY2026 | FY2024 | FY2023 | FY2022 | FY2021 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -23.7% | -2.6% | +34.7% | +3.9% | +41.0% | +8.8% | +21.2% | +36.8% | +9.9% | +6.9% |
| Net income growth | — | -194.7% | -46.2% | +44.2% | +365.3% | -57.9% | +182.8% | — | — | — |
| EPS growth | — | -195.3% | -46.2% | +42.9% | +366.7% | -60.0% | +172.7% | — | — | — |
| Free cash flow growth | — | — | -120.4% | -41.9% | +141.6% | -20.1% | +49.2% | +482.3% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2026-01-02. Facts plus Stocktoria's own computed scores — not investment advice.